IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
学科主题感染疾病科
奥沙利铂致肝窦阻塞综合征及其防治
其他题名Oxaliplatin induced hepatic sinusoidal obstruction syndrome:prevention and treatment
杨婉娜; 侯凤琴
关键词奥沙利铂 肝静脉闭塞性疾病 诊断 Oxaliplatin Hepatic Veno-occlusive Disease Diagnosis
刊名药物不良反应杂志
2015
DOI10.3760/cma.j.issn.1008-5734.2015.04.010
4页:291-295
收录类别中国科技核心期刊 ; CSCD
文章类型Journal Article
摘要奥沙利铂为第三代铂类化合物,常用于结直肠癌的化疗。奥沙利铂可损害肝窦内皮细胞引起肝窦阻塞综合征(HSOS),发生率高达77.4%。HSOS 临床表现为肝区疼痛、体重增加、腹水、肝肿大和黄疸;病理学特征为肝窦扩张充血、小叶中央静脉纤维性阻塞、窦周纤维化、小叶中央肝细胞坏死等。奥沙利铂致 HSOS 缺乏特异的影像学表现、生物学标志及特效治疗药物,对奥沙利铂所致HSOS 应以预防为主。贝伐珠单抗、瑞戈非尼、索拉菲尼、重组人可溶性血栓调节蛋白、抗氧化剂等对于 HSOS 的预防可能有一定作用,去纤苷有望用于 HSOS 的治疗。 Oxaliplatin is the third generation of platinum drugs,used in chemotherapy of colorectal carcinoma. Oxaliplatin can injure hepatic sinusoidal endothelial cells to induce hepatic sinusoidal obstruction syndrome(HSOS). The incidence of oxaliplatin induced HSOS was 77. 4% . The clinical manifestations were hepatalgia,weight gain,ascites,hepatomegaly and jaundice. Histopathologic features include hepatic sinusoidal dilation and congestion,centrilobular vein obstruction,perisinusoidal fibrosis and centrilobular hepatic cell necrosis. The lack of typical imaging manifestations,biomarkers and effective treatment,so prevention-oriented strategy is important. Bevacizumab,regorafenib,sorafenib,recombinant human soluble thrombomodulin,and antioxidant may prevent HSOS. Defibrotide is recommended for treatment of HSOS.
语种中文
原文出处查看原文
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/41903
Collection北京大学第一临床医学院_感染疾病科
作者单位100034,北京大学第一医院感染疾病科
Recommended Citation
GB/T 7714
杨婉娜,侯凤琴. 奥沙利铂致肝窦阻塞综合征及其防治[J]. 药物不良反应杂志,2015(4):291-295.
APA 杨婉娜,&侯凤琴.(2015).奥沙利铂致肝窦阻塞综合征及其防治.药物不良反应杂志(4),291-295.
MLA 杨婉娜,et al."奥沙利铂致肝窦阻塞综合征及其防治".药物不良反应杂志 .4(2015):291-295.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[杨婉娜]'s Articles
[侯凤琴]'s Articles
百度学术
百度学术Similar articles in
[杨婉娜]'s Articles
[侯凤琴]'s Articles
必应学术
必应学术Similar articles in
[杨婉娜]'s Articles
[侯凤琴]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.